首页> 外文期刊>Biochimie >Telomerase redefined: Integrated regulation of hTR and hTERT for telomere maintenance and telomerase activity
【24h】

Telomerase redefined: Integrated regulation of hTR and hTERT for telomere maintenance and telomerase activity

机译:重新定义端粒酶:hTR和hTERT的整合调节,以维持端粒和端粒酶活性

获取原文
获取原文并翻译 | 示例
       

摘要

Telomerase activity is dependent on the expression of 2 main core component genes, hTERT, which encodes the catalytic component and hTR (also called TERC), which encodes the RNA component. The correlation between telomerase activity and carcinogenesis has made this molecule of great interest in cancer research, however in order to fully understand the regulation of telomerase the mechanisms controlling both telomerase genes need to be studied. Some of these mechanisms of regulation have begun to emerge, however many more remain to be deciphered.For many years hTERT has been regarded as the limiting component of telomerase and much of the research in this field has focussed on its regulation, however it was clear from an early stage that hTR expression was also tightly regulated in normal cells and disease. More recently evidence from biochemistry, promoter studies and mouse models has been steadily increasing for a role for hTR as a limiting and essential component for telomerase activity and telomere maintenance. Perhaps the time has come to redefine our view of telomerase regulation. Knowledge of the mechanisms controlling both telomerase genes in normal systems and cancer may aid our understanding of the role of telomerase in carcinogenesis or highlight potential areas for therapeutic intervention. Here we review the essential requirement of hTR for telomere maintenance and telomerase activity in normal tissues and disease and focus on recent advances in our understanding of hTR regulation in relation to hTERT.
机译:端粒酶活性取决于2个主要核心成分基因的表达,hTERT编码催化成分,hTR(也称为TERC)编码RNA成分。端粒酶活性与致癌性之间的相关性使该分子在癌症研究中引起了极大的兴趣,但是,为了充分理解端粒酶的调控,需要研究控制端粒酶基因的机制。这些调节机制中的一些已经开始出现,但是还有许多尚待破译。多年来,hTERT被认为是端粒酶的限制性成分,并且该领域的许多研究都集中在其调节上,但是很明显从早期开始,hTR表达在正常细胞和疾病中也受到严格调节。最近,来自生物化学,启动子研究和小鼠模型的证据一直在稳步增加,因为hTR作为端粒酶活性和端粒维持的限制性和必不可少的成分。也许是时候重新定义我们对端粒酶调节的看法了。了解控制正常系统和癌症中端粒酶基因的机制可能有助于我们了解端粒酶在致癌作用中的作用,或突出治疗干预的潜在领域。在这里,我们回顾了hTR对正常组织和疾病中端粒的维持和端粒酶活性的基本要求,并着重于我们对hTERT相关hTR调控的了解的最新进展。

著录项

  • 来源
    《Biochimie》 |2008年第1期|p.13-23|共11页
  • 作者

    C.J. Cairney; W.N. Keith;

  • 作者单位
  • 收录信息 美国《科学引文索引》(SCI);美国《化学文摘》(CA);
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 生物化学;
  • 关键词

  • 入库时间 2022-08-18 01:24:10

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号